Omega Packaging Hit With Form 483 for Inadequate Test Methods, Other Lapses

The FDA rapped Omega Packaging Corp with a nine-observation Form 483 following an inspection of its Totowa, N.J., facility for deficient test methods and other lapses in its manufacture of hand sanitizers.
Source: Drug Industry Daily